HIMPP partners provide more than 90% of hearing instruments worldwide
The objective of HIMPP is to clear the road of unjust IP obstacles, thus enabling the development of the most advanced and cost effective hearing instruments to the benefit of the hearing impaired. Any company doing business within the field of hearing instruments are welcome to join HIMPP either as a full member or as a FRAND licensee whatever best suits their purpose. HIMPP currently comprises both Hearing Aid manufacturers, Hearing Aid Component manufacturers and Over-the-counter (OTC) Hearing Assistive Device manufacturers. Only a very small fraction of the Intellectual Property (IP) in the Hearing Aid Technology Space is owned by HIMPP, and all HIMPP partners have their own IP portfolios.
News:
February 8, 2021
HIMPP has acquired the entire patent portfolio of iHear Medical Inc.. The acquisition is the largest single acquisition by HIMPP, since its foundation 25 years ago in 1996. Read more
September 28, 2020
HIMPP has acquired the patent portfolio of Acouva Inc.. Read more
August 8, 2020
HIMPP has acquired patents from ExSilent Research. Read more
February 1, 2020
Stefan Launer is new Chairman of the Board of Directors in HIMPP. Read more.
November 19, 2019
The Hearing Instruments Manufacturers Patent Partnership (HIMPP) and Intellectual Ventures (IV) enter a License Agreement. Read more
October 1, 2019
US Patent 10433074 "Hearing augmentation systems and methods" has been granted to HIMPP. (Oct 1, 2019)
June 1, 2019
European Patent Attorney Hans Jørgen Rindorf joins HIMPP in support of our increasing activities.
April 19, 2018
A new HIMPP Code of Conduct has been ratified. Read more
April 19, 2018
Søren Westermann steps back after 22 years as CEO of HIMPP, but remains on the Board of Directors.
The new CEO as of April 19, 2018 is former COO of HIMPP Stinus Jeppesen. Read more
March 30, 2018
HIMPP has acquired patents from SoundID and SoundHawk. Read more
April 28, 2017
HIMPP has acquired patents from Galler. Read more
January 1, 2017
HIMPP reduces running royalty from 3% to 1%, but increases partner entry share price as of 1 July 2017. Read more
